[vc_row][vc_column][vc_column_text css=”.vc_custom_1655539952615{margin-bottom: 0px !important;}”]Last week we uncovered the list of drug patents expiring in 2028. But can highfliers like you and I stop at that?
Well, rest your numbing tendons for we’re here with the list of drug patents expiring in 2029. The list includes not just the drug names but also other information like yearly sales, treatment, ingredients, and the disease they cure which could help them (you) easily choose the drug most profitable to develop a generic version.
Without any delay, here is the list of drugs. Thank us later!
The article has a list of drug patents expiring in 2029. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][mk_fancy_title color=”#2878bf” size=”32″ line_height=”80″ font_weight=”bolder” txt_transform=”uppercase” margin_bottom=”0″ font_family=”none”]Drug Patents Expiring in 2029[/mk_fancy_title][mk_divider margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Lamictal Odt
Lamotrigine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7919115 | January 4, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653373041039{margin-bottom: 0px !important;}”]Dosage: Oral
Company: GlaxoSmithKline
Ingredients: LAMOTRIGINE
Treatment: Epilepsy[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Wakix
Pitolisant[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8207197 | February 25, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653388925484{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Harmony Biosciences Llc
Ingredients: PITOLISANT HYDROCHLORIDE
Treatment: Excessive Daytime Sleepiness[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Caplyta
Lumateperone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9586960 | March 12, 2029 |
| USRE48825 | March 12, 2029 |
| US8648077 | December 1, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653388996444{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Intra-cellular Therapies Inc
Ingredients: LUMATEPERONE TOSYLATE
Treatment: Schizophrenia And Bipolar Depression[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Desyrel
Trazodone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8133893 | March 13, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389061834{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Pragma Pharmaceuticals Llc
Ingredients: TRAZODONE HYDROCHLORIDE
Treatment: Major Depressive Disorder, Anxiety Disorders, and Difficulties With Sleep[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Neuraceq
Florbetaben[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7807135 | March 18, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389124092{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Life Molecular Imaging Ltd
Ingredients: FLORBETABEN F-18
Treatment: Alzheimer’s Disease[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Monoferric
Ferric derisomaltose[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US10414831 | March 25, 2029 |
| US8815301 | August 14, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389190127{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Pharmacosmos As
Ingredients: FERRIC DERISOMALTOSE
Treatment: Iron Deficiency Anemia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Gemtesa
Vibegron[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8653260 | April 2, 2029 |
| US8247415 | December 1, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1653389252852{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Urovant Sciences Gmbh
Ingredients: VIBEGRON
Treatment: Overactive Bladder[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Kerendia
Finerenone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8436180 | April 12, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389328068{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bayer Healthcare Pharmaceuticals Inc
Ingredients: FINERENONE
Treatment: Kidney Function[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Triferic
Ferric Pyrophosphate Citrate[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7816404 | April 17, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389384604{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Rockwell Medical Inc
Ingredients: FERRIC PYROPHOSPHATE CITRATE
Treatment: Iron Deficiency Anemia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Cipro
Ciprofloxacine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9603796 | April 21, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389450683{margin-bottom: 0px !important;}”]Dosage: Oral, Intravenous, Topical
Company: Alk-abello Inc
Ingredients: CIPROFLOXACIN
Treatment: Bacterial Infections[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Veklury
Remdesivir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| USRE46762 | April 22, 2029 |
| US8318682 | April 22, 2029 |
| US8008264 | September 6, 2029 |
| US10065958 | September 16, 2031 |
| US9724360 | October 29, 2035 |
| US9949994 | October 29, 2035 |
[/mk_table][vc_column_text css=”.vc_custom_1653389557460{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Gilead Sciences Inc
Ingredients: REMDESIVIR
Treatment: Antiviral[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zejula
Niraparib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8436185 | April 24, 2029 |
| US8071623 | March 27, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653389638547{margin-bottom: 0px !important;}”]Dosage: Oral
Company: GlaxoSmithKline Llc
Ingredients: NIRAPARIB TOSYLATE
Treatment: Anti-cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zeposia
Ozanimod[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8481573 | May 14, 2029 |
| US8796318 | May 14, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389700021{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Celgene International Ii Sarl
Ingredients: OZANIMOD HYDROCHLORIDE
Treatment: Multiple Sclerosis And Ulcerative Colitis[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tauvid
Flortaucipir (18F)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8932557 | May 19, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389764846{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Avid Radiopharmaceuticals Inc
Ingredients: FLORTAUCIPIR F-18
Treatment: Radioactive Diagnostic Agent[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Opana Er
Oxymorphone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7851482 | July 10, 2029 |
| US8871779 | November 22, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653389837154{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Endo Pharmaceuticals Inc
Ingredients: OXYMORPHONE HYDROCHLORIDE
Treatment: Severe Pain[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Braftovi
Encorafenib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8946250 | July 23, 2029 |
| US8541575 | February 26, 2030 |
| US9593099 | August 27, 2030 |
| US8501758 | March 4, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653389926350{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Array Biopharma Inc
Ingredients: ENCORAFENIB
Treatment: Melanoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Odomzo
Sonidegib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8178563 | July 24, 2029 |
| US8063043 | September 15, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653390013781{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Sun Pharmaceutical Industries Ltd
Ingredients: SONIDEGIB PHOSPHATE
Treatment: Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zepatier
Elbasvir/Grazoprevir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7973040 | July 24, 2029 |
| US8871759 | May 4, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653390155119{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Merck Sharp And Dohme Corp
Ingredients: ELBASVIR; GRAZOPREVIR
Treatment: Hepatitis C[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row]
[vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Talzenna
Talazoparib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8420650 | July 27, 2029 |
| US8012976 | October 19, 2029 |
| US10189837 | October 20, 2031 |
| US8735392 | October 20, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653390239597{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Pfizer Inc
Ingredients: TALAZOPARIB TOSYLATE
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Evotaz
Atazanavir/Cobicistat[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8148374 | September 3, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653390355476{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bristol-Myers Squibb Co
Ingredients: ATAZANAVIR SULFATE; COBICISTAT
Treatment: HIV/AIDS[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Piqray
Alpelisib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8476268 | September 10, 2029 |
| US8227462 | September 28, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1653390423702{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: ALPELISIB
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tykerb
Lapatinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8821927 | September 18, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653390522854{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: LAPATINIB DITOSYLATE
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Treanda
Bendamustine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8445524 | September 26, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653390589760{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Cephalon Inc
Ingredients: BENDAMUSTINE HYDROCHLORIDE
Treatment: Chronic Lymphocytic Leukemia, Multiple Myeloma, And Non-Hodgkin’s Lymphoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Ingrezza
Valbenazine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8039627 | October 6, 2029 |
| US10065952 | October 28, 2036 |
| US10844058 | October 28, 2036 |
| US10851103 | October 28, 2036 |
| US10851104 | October 28, 2036 |
| US10906902 | December 22, 2036 |
| US10919892 | December 22, 2036 |
| US10906903 | December 22, 2036 |
[/mk_table][vc_column_text css=”.vc_custom_1653390726015{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Neurocrine Biosciences Inc
Ingredients: VALBENAZINE TOSYLATE
Treatment: Tardive Dyskinesia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vitrakvi
Larotrectinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9127013 | October 21, 2029 |
| US8513263 | December 23, 2029 |
| US10172861 | November 16, 2035 |
| US10799505 | August 15, 2036 |
[/mk_table][vc_column_text css=”.vc_custom_1653390844494{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bayer Healthcare Pharmaceuticals Inc
Ingredients: LAROTRECTINIB SULFATE
Treatment: Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Rezurock
Belumosudil[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8357693 | October 30, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653390955200{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Kadmon Pharmaceuticals Llc
Ingredients: BELUMOSUDIL MESYLATE
Treatment: Chronic Graft Versus Host Disease[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Cotellic
Cobimetinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7803839 | November 10, 2029 |
| US10478400 | June 29, 2036/td> |
| US10590102 | June 30, 2036 |
[/mk_table][vc_column_text css=”.vc_custom_1653391045986{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Genentech Inc
Ingredients: COBIMETINIB FUMARATE
Treatment: Anti-cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Recarbrio
Imipenem/Cilastatin/Relebactam[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8487093 | November 19, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653391130102{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Merck Sharp And Dohme
Ingredients: CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
Treatment: Urinary Tract And Complicated Intra-abdominal Infections[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Belsomra
Suvorexant[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7951797 | November 20, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653391192178{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Merck Sharp And Dohme
Ingredients: SUVOREXANT
Treatment: Insomnia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Verzenio
Abemaciclib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7855211 | December 15, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653391245916{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Eli Lilly And Co
Ingredients: ABEMACICLIB
Treatment: Breast Cancers[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tavneos
Avacopan[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8906938 | December 21, 2029 |
| US8445515 | February 3, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653391318625{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Chemocentryx Inc
Ingredients: AVACOPAN
Treatment: Anti-neutrophil Cytoplasmic Auto antibody-associated Vasculitis[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Ibsrela
Tenapanor[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8541448 | December 30, 2029 |
| US8969377 | December 30, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653391471847{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Ardelyx Inc
Ingredients: TENAPANOR HYDROCHLORIDE
Treatment: Irritable Bowel Syndrome[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Eucrisa
Crisaborole[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8039451 | December 29, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653391397087{margin-bottom: 0px !important;}”]Dosage: Topical
Company: Anacor Pharmaceuticals Inc
Ingredients: CRISABOROLE
Treatment: Atopic Dermatitis[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1655540702015{margin-bottom: 0px !important;}”]With the huge growth in the generic drug market, it has become essential for generic companies like yours to keep a tab on the drugs with a soon-to-be-expired label. But that’s not enough, you have to stay ahead of your competitors too. This is where GreyB comes in!
Our pharma team is working on its toes to extract all the drug patents expiring in the next 8 years from now. Want to get your hands on the complete list?[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row]
